Page last updated: 2024-08-21

maleimide and Angiogenesis, Pathologic

maleimide has been researched along with Angiogenesis, Pathologic in 2 studies

Research

Studies (2)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	2 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Li, J; Li, X; Li, Y; Liu, W; Mu, H; Sun, K; Wang, A; Wang, M; Wu, Z; Zhang, X	1
Dannhardt, G; Ganser, C; Kindler, T; Kramb, JP; Lauermann, E; Maderer, A; Moehler, M; Plutizki, S; Stauder, T	1

Other Studies

2 other study(ies) available for maleimide and Angiogenesis, Pathologic

Article	Year
Synthesis of a bi-functional dendrimer-based nanovehicle co-modified with RGDyC and TAT peptides for neovascular targeting and penetration. International journal of pharmaceutics, 2016, Mar-30, Volume: 501, Issue:1-2 Topics: Animals; Cell Line, Tumor; Cell Survival; Cell-Penetrating Peptides; Cells, Cultured; Dendrimers; Female; HEK293 Cells; Human Umbilical Vein Endothelial Cells; Humans; Maleimides; Mice, Inbred BALB C; Mice, Nude; Nanostructures; Neoplasms; Neovascularization, Pathologic; Oligopeptides; Peptide Fragments; Peptides, Cyclic; Polyethylene Glycols; Succinimides; tat Gene Products, Human Immunodeficiency Virus	2016
Novel 3-Azaindolyl-4-arylmaleimides exhibiting potent antiangiogenic efficacy, protein kinase inhibition, and antiproliferative activity. Journal of medicinal chemistry, 2012, Nov-26, Volume: 55, Issue:22 Topics: Angiogenesis Inhibitors; Animals; Apoptosis; Cell Cycle; Cell Proliferation; Cells, Cultured; Chick Embryo; fms-Like Tyrosine Kinase 3; Glycogen Synthase Kinase 3; Glycogen Synthase Kinase 3 beta; Growth Inhibitors; Human Umbilical Vein Endothelial Cells; Humans; Maleimides; Molecular Structure; Neoplasms; Neovascularization, Pathologic; Protein Kinase Inhibitors; Structure-Activity Relationship; Vascular Endothelial Growth Factor Receptor-2; Vascular Endothelial Growth Factor Receptor-3	2012

Article

Year

Synthesis of a bi-functional dendrimer-based nanovehicle co-modified with RGDyC and TAT peptides for neovascular targeting and penetration.

International journal of pharmaceutics, 2016, Mar-30, Volume: 501, Issue:1-2

Topics: Animals; Cell Line, Tumor; Cell Survival; Cell-Penetrating Peptides; Cells, Cultured; Dendrimers; Female; HEK293 Cells; Human Umbilical Vein Endothelial Cells; Humans; Maleimides; Mice, Inbred BALB C; Mice, Nude; Nanostructures; Neoplasms; Neovascularization, Pathologic; Oligopeptides; Peptide Fragments; Peptides, Cyclic; Polyethylene Glycols; Succinimides; tat Gene Products, Human Immunodeficiency Virus

2016

Novel 3-Azaindolyl-4-arylmaleimides exhibiting potent antiangiogenic efficacy, protein kinase inhibition, and antiproliferative activity.

Journal of medicinal chemistry, 2012, Nov-26, Volume: 55, Issue:22

Topics: Angiogenesis Inhibitors; Animals; Apoptosis; Cell Cycle; Cell Proliferation; Cells, Cultured; Chick Embryo; fms-Like Tyrosine Kinase 3; Glycogen Synthase Kinase 3; Glycogen Synthase Kinase 3 beta; Growth Inhibitors; Human Umbilical Vein Endothelial Cells; Humans; Maleimides; Molecular Structure; Neoplasms; Neovascularization, Pathologic; Protein Kinase Inhibitors; Structure-Activity Relationship; Vascular Endothelial Growth Factor Receptor-2; Vascular Endothelial Growth Factor Receptor-3

2012